Carl P. Sherr & Co., LLC Biogen Inc. Transaction History

Carl P. Sherr & Co., LLC

4 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q2 2021 Jul 21, 2021	SELL	$259.0 - $414.71 $356,384 - $570,640	-1,376 Closed	0 $0
Q1 2021 Apr 13, 2021	BUY	$242.95 - $284.63 $47,132 - $55,218	194 Added 16.41%	1,376 $385,000
Q4 2020 Feb 08, 2021	BUY	$236.26 - $355.63 $10,631 - $16,003	45 Added 3.96%	1,182 $289,000
Q3 2020 Oct 19, 2020	BUY	$264.77 - $305.71 $301,043 - $347,592	1,137 New	1,137 $323,000

1,018

128M

1.22M

1.4M

Ticker BIIB
Exchange NASDAQ
Sector Healthcare
Industry Drug Manufacturers—General
Shares Outstandng 144,000,992
Market Cap $25B
Description
Biogen Inc. discovers, develops, manufactures, and delivers therapies for treating neurological and neurodegenerative diseases. The company offers TECFIDERA, VUMERITY, AVONEX, PLEGRIDY, TYSABRI, and FAMPYRA for multiple sclerosis (MS); SPINRAZA for spinal muscular atrophy; and FUMADERM to treat plaque psoriasis. It also provides BENEPALI, an eta...

Get notified when there are updates to the investment portfolio of Carl P. Sherr & Co., LLC, based on Form 13F filings with the SEC.

Stay updated on Carl P. Sherr & Co., LLC with notifications on news.